At a glance
- Originator Wyeth
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action 5-lipoxygenase inhibitors; Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 11 Oct 2000 No-Development-Reported for Inflammation in USA (Unknown route)
- 11 Oct 2000 No-Development-Reported for Rheumatic disorders in USA (Unknown route)